Contact
Please use this form to send email to PR contact of this press release:
Neuren’s Phase 2 trial of trofinetide demonstrates significant clinical benefit in pediatric Rett syndrome
TO:
Please use this form to send email to PR contact of this press release:
Neuren’s Phase 2 trial of trofinetide demonstrates significant clinical benefit in pediatric Rett syndrome
TO: